Ultragenyx (RARE) is up 13.0%, or $2.57 to $22.29.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RARE:
- DigitalBridge downgraded, Commvault initiated: Wall Street’s top analyst calls
- Ultragenyx removed from Analyst Focus List at JPMorgan
- Wells cuts Ultragenyx target, not throwing in the towel yet
- Mereo BioPharma downgraded to Hold from Buy at Jefferies
- Ultragenyx price target lowered to $63 from $114 at Jefferies
